Pages that link to "Q36633084"
Jump to navigation
Jump to search
The following pages link to Antigenic specificities of human CD4 T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. (Q36633084):
Displaying 50 items.
- Mucosal resident memory CD4 T cells in protection and immunopathology (Q26823137) (← links)
- Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening. (Q27303136) (← links)
- Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected Subjects (Q27486108) (← links)
- Asymptomatic human CD4 cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B (Q30847945) (← links)
- CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins (Q30957753) (← links)
- Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes (Q33248961) (← links)
- Contrasting roles for TLR ligands in HIV-1 pathogenesis (Q33700312) (← links)
- Herpes simplex virus type 2 vaccines: new ground for optimism? (Q33711912) (← links)
- Public TCR use by herpes simplex virus-2-specific human CD8 CTLs. (Q33824488) (← links)
- Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. (Q33826410) (← links)
- Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission (Q33850188) (← links)
- Recent progress in herpes simplex virus immunobiology and vaccine research (Q33963713) (← links)
- Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4 T lymphocytes specific for herpes simplex virus type 2. (Q34081662) (← links)
- Homing in on the cellular immune response to HSV-2 in humans. (Q34081670) (← links)
- Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection (Q34470969) (← links)
- Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs (Q34653920) (← links)
- Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease (Q34742583) (← links)
- Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig (Q34856138) (← links)
- Human CD4 CD25 high cells suppress proliferative memory lymphocyte responses to herpes simplex virus type 2. (Q35024021) (← links)
- Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitis (Q35066312) (← links)
- Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models (Q35271194) (← links)
- Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood. (Q35510910) (← links)
- Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine (Q35699002) (← links)
- Schistosoma mansoni Infection in Ugandan Men Is Associated with Increased Abundance and Function of HIV Target Cells in Blood, but Not the Foreskin: A Cross-sectional Study (Q35763313) (← links)
- Immunodominant “Asymptomatic” Herpes Simplex Virus 1 and 2 Protein Antigens Identified by Probing Whole-ORFome Microarrays with Serum Antibodies from Seropositive Asymptomatic versus Symptomatic Individuals (Q35868029) (← links)
- Discovery of Potential Diagnostic and Vaccine Antigens in Herpes Simplex Virus 1 and 2 by Proteome-Wide Antibody Profiling (Q35868054) (← links)
- A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8 T cells and protects against herpes simplex virus type 2 challenge (Q35871689) (← links)
- High frequency of CD8 cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes (Q35872807) (← links)
- A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens (Q35914367) (← links)
- Zoster Vaccination Increases the Breadth of CD4 T Cells Responsive to Varicella Zoster Virus (Q36024466) (← links)
- Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females (Q36173112) (← links)
- Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes (Q36246306) (← links)
- HLA-DQB1 codon 57 is critical for peptide binding and recognition. (Q36365882) (← links)
- Varicella-zoster virus transfer to skin by T Cells and modulation of viral replication by epidermal cell interferon-alpha (Q36403830) (← links)
- Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2. (Q36555158) (← links)
- Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8 cytotoxic T lymphocyte responses (Q36585733) (← links)
- Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses (Q36601101) (← links)
- Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor (Q36689912) (← links)
- An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs (Q36759693) (← links)
- Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D. (Q36898071) (← links)
- Effector CD4 T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords (Q36898906) (← links)
- Phase I study of a herpes simplex virus type 2 (HSV-2) DNA vaccine administered to healthy, HSV-2-seronegative adults by a needle-free injection system (Q36974311) (← links)
- T-cell immunity to human alphaherpesviruses (Q37107189) (← links)
- High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection (Q37160338) (← links)
- Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition (Q37295563) (← links)
- Cross-regulation between herpesviruses and the TNF superfamily members (Q37307520) (← links)
- Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes (Q37380356) (← links)
- Worldwide circulation of HSV-2 × HSV-1 recombinant strains (Q37695200) (← links)
- Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses (Q37963480) (← links)
- Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival (Q38721030) (← links)